Resistance of α-synuclein null mice to the parkinsonian neurotoxin MPTP

被引:455
作者
Dauer, W [1 ]
Kholodilov, N
Vila, M
Trillat, AC
Goodchild, R
Larsen, KE
Staal, R
Tieu, K
Schmitz, Y
Yuan, CA
Rocha, M
Jackson-Lewis, V
Hersch, S
Sulzer, D
Przedborski, S
Burke, R
Hen, R
机构
[1] Columbia Univ, Dept Neurol, New York, NY 10027 USA
[2] Columbia Univ, Dept Pathol, New York, NY 10027 USA
[3] Columbia Univ, Dept Psychiat, New York, NY 10027 USA
[4] Columbia Univ, Dept Pharmacol, New York, NY 10027 USA
[5] Columbia Univ, Ctr Neurobiol & Behav, New York, NY 10027 USA
[6] New York State Psychiat Inst & Hosp, Dept Neurosci, New York, NY 10027 USA
[7] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Neurol, Boston, MA 02114 USA
关键词
D O I
10.1073/pnas.172514599
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Parkinson's disease (PD) is most commonly a sporadic illness, and is characterized by degeneration of substantia nigra dopamine (DA) neurons and abnormal cytoplasmic aggregates of alpha-synuclein. Rarely, PD may be caused by missense mutations in alpha-synuclein. MPTP, a neurotoxin that inhibits mitochondrial complex I, is a prototype for an environmental cause of PD because it produces a pattern of DA neurodegeneration that closely resembles the neuropathology of PD. Here we show that alpha-synuclein null mice display striking resistance to MPTP-induced degeneration of DA neurons and DA release, and this resistance appears to result from an inability of the toxin to inhibit complex I. Contrary to predictions from in vitro data, this resistance is not due to abnormalities of the DA transporter, which appears to function normally in alpha-synuclein null mice. Our results suggest that some genetic and environmental factors that increase susceptibility to PD may interact with a common molecular pathway, and represent the first demonstration that normal alpha-synuclein function may be important to DA neuron viability.
引用
收藏
页码:14524 / 14529
页数:6
相关论文
共 38 条
  • [1] Mice lacking α-synuclein display functional deficits in the nigrostriatal dopamine system
    Abeliovich, A
    Schmitz, Y
    Fariñas, I
    Choi-Lundberg, D
    Ho, WH
    Castillo, PE
    Shinsky, N
    Verdugo, JMG
    Armanini, M
    Ryan, A
    Hynes, M
    Phillips, H
    Sulzer, D
    Rosenthal, A
    [J]. NEURON, 2000, 25 (01) : 239 - 252
  • [2] AN ASSESSMENT OF THE VALIDITY OF DENSITOMETRIC MEASURES OF STRIATAL TYROSINE HYDROXYLASE-POSITIVE FIBERS - RELATIONSHIP TO APOMORPHINE-INDUCED ROTATIONS IN 6-HYDROXYDOPAMINE LESIONED RATS
    BURKE, RE
    CADET, JL
    KENT, JD
    KARANAS, AL
    JACKSONLEWIS, V
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 1990, 35 (01) : 63 - 73
  • [3] Burrows KB, 2000, J PHARMACOL EXP THER, V292, P853
  • [4] Anoxia-induced dopamine release from rat striatal slices:: Involvement of reverse transport mechanism
    Büyükuysal, RL
    Mete, B
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 72 (04) : 1507 - 1515
  • [5] Parkin ubiquitinates the α-synuclein-interacting protein, synphilin-1:: implications for Lewy-body formation in Parkinson disease
    Chung, KKK
    Zhang, Y
    Lim, KL
    Tanaka, Y
    Huang, H
    Gao, J
    Ross, CA
    Dawson, VL
    Dawson, TM
    [J]. NATURE MEDICINE, 2001, 7 (10) : 1144 - 1150
  • [6] Kinetic stabilization of the α-synuclein protofibril by a dopamine-α-synuclein adduct
    Conway, KA
    Rochet, JC
    Bieganski, RM
    Lansbury, PT
    [J]. SCIENCE, 2001, 294 (5545) : 1346 - 1349
  • [7] A Drosophila model of Parkinson's disease
    Feany, MB
    Bender, WW
    [J]. NATURE, 2000, 404 (6776) : 394 - 398
  • [8] Malonate-induced generation of reactive oxygen species in rat striatum depends on dopamine release but not on NMDA receptor activation
    Ferger, B
    Eberhardt, O
    Teismann, P
    de Groote, C
    Schulz, JB
    [J]. JOURNAL OF NEUROCHEMISTRY, 1999, 73 (03) : 1329 - 1332
  • [9] TIME-COURSE AND MORPHOLOGY OF DOPAMINERGIC NEURONAL DEATH CAUSED BY THE NEUROTOXIN 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE
    JACKSONLEWIS, V
    JAKOWEC, M
    BURKE, RE
    PRZEDBORSKI, S
    [J]. NEURODEGENERATION, 1995, 4 (03): : 257 - 269
  • [10] UPTAKE OF MPP(+) BY DOPAMINE NEURONS EXPLAINS SELECTIVITY OF PARKINSONISM-INDUCING NEUROTOXIN, MPTP
    JAVITCH, JA
    SNYDER, SH
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1984, 106 (02) : 455 - 456